Tumor Immunology and Immunotherapy

Nov. 17-20, 2019
Boston Marriott Copley Place
Boston, Massachusetts

Abstract Submission and Award Application Deadline: Thursday, Sept. 5, 2019
Advance Registration Deadline: Monday, Oct. 7, 2019

Conference Cochairs
Timothy A. Chan, Memorial Sloan Kettering Cancer Center, New York, New York
Charles G. Drake
, Columbia University Medical Center, New York, New York
Marcela V. Maus
, Massachusetts General Hospital, Boston, Massachusetts
Arlene H. Sharpe, Harvard Medical School, Charlestown, Massachusetts

This AACR Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, nonimmunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of the microbiome; adverse immunologic events; imaging and other new technologies; genetics and epigenomics of immuno-oncology; and immunologic signaling pathways. These world-renowned oncologists and researchers will offer their insights on novel cell therapies, biomarkers, vaccines, and adjuvants, all in the pursuit of understanding tumor evolution and creating better treatments. Please join in the conversation and network with investigators, from basic to translational scientists, from academia to industry.

Professional Educational Grants






Bristol-Myers Squibb 


CME-MOC_badge_170x.jpgContinuing Medical Education Activity AMA PRA Category 1 CreditsTM available